Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2025-12-25 @ 10:25 PM
Study NCT ID:
NCT05627258
Status:
COMPLETED
Last Update Posted:
2025-08-22
First Post:
2022-11-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRCHIVMAB0115-00-AB (VRC01.23LS), Administered Intravenously or Subcutaneously to Healthy Adults
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-30
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-17
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-23
First Submit QC Date:
None
Study First Post Date:
2022-11-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-11
Results First Submit QC Date:
None
Results First Post Date:
2025-08-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-08
Last Update Post Date:
2025-08-22
Last Update Post Date Type:
ACTUAL